Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Significant experimental decrease of the hepatocarcinoma (HPC) incidence in C3H/SY mice after administration of EB1089, a vitamin D analogue, European Journal of Cancer, April 2001, Elsevier,
DOI: 10.1016/s0959-8049(01)80769-3.
You can read the full text:
Contributors
The following have contributed to this page
